Mohamed Zaki

CIK 2000697 · Chief Medical Officer · last filed 2026-07-02

Mohamed Zaki is a Chief Medical Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for ADCT, was dated Jul 2, 2026. Current disclosed insider exposure totals $990.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$990.4K

Companies

1

Total Filings

5

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ADCT	Chief Medical Officer	896,317	$1.10	$990.4K	$0	5	2026-07-02

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-02	ADCT	Grant (A)	+213,900	$0	EDGAR
2026-02-18	ADCT	Mixed	+260,597	$1.04M	EDGAR
2025-12-09	ADCT	Tax (F)	−41,068	-$135.1K	EDGAR
2025-02-14	ADCT	Grant (A)	+230,000	$370.3K	EDGAR
2024-12-09	ADCT	Tax (F)	−37,112	-$116.2K	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.